Posted on 7/30/19
Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has granted unconditional approval of Bristol-Myers Squibb’s pending acquisition of Celgene Corporation . . .
Posted on 7/29/19
Cara Therapeutics Closes Public Offering of Common Stock
STAMFORD, Conn., July 29, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed . . .
Posted on 7/29/19
Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch
Mylan's Board of Directors today shared the following statement regarding Heather Bresch's retirement, which will be effective upon the closing of the combination of Mylan and . . .
Posted on 7/29/19
Pfizer Reports Second-Quarter 2019 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2019 and updated certain components of its 2019 financial guidance.2019 FINANCIAL GUIDANCE(6)Pfizer’s updated 2019 financial . . .
Posted on 7/29/19
Johnson & Johnson et al: Rumored $100B Opioid Settlement Could Upend Pain Management Companies
SummaryIn my previous article on this top, I asserted that a Washington Post exposé on the opioid epidemic was largely irrelevant to the stocks involved.That is . . .
Posted on 7/26/19
Pfizer Continues To Build Its Long-Term Potential
SummaryPfizer is one of the largest pharmaceutical companies in an industry where size brings financial stability and the pockets to make blockbuster acquisitions.The company's acquisition of . . .
Posted on 7/26/19
Cara Therapeutics Proposes Offering of Common Stock
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed . . .
Posted on 7/26/19
Advaxis Closes $17M Public Offering
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the closing of its . . .
Posted on 7/25/19
Rightway Healthcare Announces Strategic Partnership with United Benefit Advisors
NEW YORK--(BUSINESS WIRE)--Rightway Healthcare, a New York-based patient navigation and healthcare advocacy platform for employers and their employees, today announced that it has been awarded the . . .
Posted on 7/25/19
Johnson & Johnson's Stock May Be Too Cheap In A Low Interest Rate World
SummaryJohnson & Johnson's dividend yield is 80 basis points higher than the 10-year.The stock is trading at a low earnings multiple historically.The multiple also is lower . . .
Posted on 7/24/19
Engagement Labs Secures Contract With Global Video Game Company
Engagement Labs Inc. (TSXV: EL) announced today that it has successfully secured a multi-national contract with a leading global video game company. The one-year agreement is . . .
Posted on 7/24/19
The Medicines Company Reports Second-Quarter 2019 Financial Results and Updates Clinical Development Program
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today reported financial results for the second quarter that ended June 30, 2019. Second quarter highlights included significant progress . . .
Posted on 7/24/19
Integra LifeSciences Reports Second Quarter 2019 Financial Results
PLAINSBORO, N.J., July 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the . . .
Posted on 7/23/19
Advaxis Announces Pricing of $16 Million Public Offering
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the pricing of an . . .
Posted on 7/23/19
UCI Health Partners With Connexient To Connect
Connexient announced today an initiative with UCI Health in Orange County, Calif., to integrate the MediNav solution with the UCI Mobile app; a mobile app for patients . . .
Posted on 7/23/19
Quest Diagnostics Reports Second Quarter 2019 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2019."Our volume . . .
Posted on 7/23/19
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) is one of the premier blue-chip stocks. It's the largest healthcare company in the world. But J&J stock is underperforming the S&P . . .
Posted on 7/23/19
ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals
EDISON, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of . . .
Posted on 7/22/19
Johnson & Johnson: Getting Attractive As It Sinks Towards $130
SummaryJNJ continues to face negative news headlines regarding talc powder issues.In recent years, these concerns have led to sell-offs, and late last week when news broke . . .
Posted on 7/22/19
Better Buy: Pfizer vs. AbbVie
Pfizer (NYSE:PFE) and AbbVie (NYSE:ABBV) have a lot in common. Both big drugmakers are about to experience the impact of a major blockbuster losing market share. . . .
Posted on 7/22/19
Amarin Prices Public Offering of American Depositary Shares
BEDMINSTER, N.J. and DUBLIN, Ireland, July 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced the pricing of the underwritten public offering of . . .
Posted on 7/22/19
Tonix Pharmaceuticals Closes Public Offering of Common Stock
NEW YORK, July 18, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the closing . . .
Posted on 7/21/19
Rising Pharmaceuticals Announces the U.S. Launch of a Generic Version of Pregabalin Capsules
SADDLEBROOK, N.J.--(BUSINESS WIRE)--Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, . . .
Posted on 7/19/19
5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report
Getting the world's largest healthcare company to grow even larger isn't easy, but Johnson & Johnson(NYSE:JNJ) has pulled it off with legendary consistency. Earlier this year, . . .
Posted on 7/19/19
The Kinetix Group has Been Recognized by Medical Marketing & Media as a Top 100 Healthcare Agency
The Kinetix Group (TKG), a New York City-based life sciences marketing agency and care delivery consultancy, has been recognized by Medical Marketing & Media (MM&M) as . . .

